Call the Florida Seniors Pradaxa Helpline and speak to a geriatric social worker and a Pradaxa lawyer. Pradaxa helpline Florida’s geriatric social worker is concerned about fatalities of the elderly while on Pradaxa. pradaxa can cause brain hemmorhages.
Florida Pradaxa Lawyers and The Pradaxa Helpline are listening to our Florida Senior Population regarding Pradaxa injury and deaths. As a geriatric Social worker I am concerned about seniors on Pradaxa. The Pradaxa helpline can help you in: Belle Glade, Boca Raton, Bonita Springs, Boynton Beach, Bradenton, Cape Coral, Clearwater, Coral Gables, Coral Springs, Daytona Beach, Deerfield Beach, DeLand, Delray Beach ,Fort Lauderdale, Fort Myers, Fort Pierce, Fort Walton Beach, Gainesville, Haines City, Hallandale Beach, Hialeah, Hollywood, Homestead, Immokalee, Jacksonville, Key West, Kissimmee, Lakeland, Largo, Melbourne, Merritt Island, Miami, Miami Beach, Naples, New Smyrna Beach, Ocala, Orlando, Ormond Beach, Palm Bay, Panama City, Pensacola, Plant City, Pompano Beach, Port Charlotte, Port Saint Lucie, St Cloud, St. Petersburg, Sarasota, Spring Hill, Starke, Tallahassee, Tampa, Tarpon Springs, Titusville, Venice, Vero Beach, West Palm Beach, Pensacola, Winter Haven, Winter Park,for a Pradaxa lawyer
Florida Pradaxa Breaking News, Pradaxa lawyers filing lawsuits for pradaxa
According to Cleveland Clinic researchers, Pradaxa patients taking the new anti-clotting drug Pradaxa have a 33% higher risk of heart attack or severe symptoms of heart disease than do patients taking warfarin.
This finding, from Ken Uchino, MD, and Adrian V. Hernandez, MD, PhD, is based on data from seven clinical trials that enrolled 30,514 patients.
According to Uchino and Hernandez, “the risk of [heart attack] or acute coronary syndrome is increased with [Pradaxa] compared with various control treatments, which include adjusted-dose warfarin, [Lovenox], or placebo.”
Pradaxa side effects include uncontrolled internal bleeding or death. According to a recent report by Bloomberg news service, Pradaxa manufacturer Boehringer Ingelheim said the drug has been linked to 250 deaths worldwide.
Adverse Pradaxa Incident Reports for Extensive Bleeding
Familiarity with Pradaxa is critical in order for caregivers and EMS responders to take quick action to control catastrophic bleeding.
Researchers speculated that dialysis might remove 35 percent to 60 percent of Pradaxa from the bloodstream in two to three hours, but noted that option was not taken with the elderly patient. “By the time of his deterioration it was too late to implement effectively.”
Since balance problems and falls are common for elderly patients, cases of brain hemorrhage even from a minor trauma are likely to increase as more patients get prescribed Pradaxa, the researchers said.
“Bleeding is unfortunately one of the adverse effects of all anticoagulants,” said John Smith, senior vice president for clinical development at Boehringer Ingelheim.
Although there is no antidote to Pradaxa that could control bleeding, including among fall victims like the elderly man, Smith said patients taking Pradaxa in a large clinical trial had a 59 percent lower overall incidence of intracranial bleeding than patients taking warfarin.
Pradaxa was approved by U.S. regulators in October 2010 for stroke prevention in patients with atrial fibrillation. It is the first of a new crop of blood clot preventers meant to replace warfarin — a longtime oral treatment that carries serious bleeding risks and requires routine blood monitoring and stringent dietary restrictions.
The report said patients taking the highest dose of Pradaxa in a large clinical trial sponsored by Boehringer had a similar overall rate of brain hemorrhage as those taking warfarin, while having a lower annual incidence of stroke. But the lack of a reversal agent in the event of catastrophic hemorrhage remains a handicap, they said.
The new medicine from privately held German drugmaker Boehringer Ingelheim competes with Xarelto, a pill from Johnson & Johnson and Bayer AG, approved four months ago in the United States that works by blocking a protein called Factor Xa.
Another Factor Xa inhibitor from Bristol-Myers Squibb Co and Pfizer Inc, called Eliquis, is being reviewed by the U.S. Food and Drug Administration for approval.
It is deemed by Wall Street to be the best of the new oral anticoagulants because it proved both safer and more effective than warfarin in large clinical trials. Industry analysts have speculated Eliquis could reap annual sales of $4 billion or more
At the Pradaxa Helpline Florida we work with Pradaxa lawyers and are receiving feedback of increasing numbers of lawsuits for Pradaxa brain hemmorhage. For information Call the pradaxa helpline.